A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism

Grants and Contracts Details

StatusFinished
Effective start/end date10/25/103/31/12

Funding

  • Pfizer Inc.: $4,597.00